Peptide Tracker - Pepty
By Unsal Oner
Peptide Tracker - Pepty is a free health utility for tracking peptide protocols, doses, and inventory on iOS.
The App DNA
What makes this app unique?
The app removes the need for manual spreadsheets and disparate reminder tools, reducing the risk of dosing errors for users managing complex health regimens.
For Individuals managing peptide protocols for health and fitness who require a centralized tool for tracking doses and inventory.
What does it look like?
Key features
Customizable schedules and dosages centralize user workflow, increasing daily app usage frequency.
Automated supply monitoring with vial concentration and photo logging reduces user friction by preventing supply gaps.
Built-in tools for reconstitution and syringe conversion provide utility that increases switching costs.
How much does it cost?
The app operates as a free utility with no monetization, likely serving as a portfolio piece for the developer.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the last 86 days. Development is focused on stability and minor UX refinements, such as injection site recommendations and inventory tracking improvements. There is no evidence of a recurring live-ops schedule or rapid feature iteration. The current pace suggests a focus on long-term stability rather than active expansion.
Who built it?
Unsal Oner
7 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Peptide Tracker - Pepty
How's the Health & Fitness market?
Peptide Tracker - Pepty occupies a niche utility space within the Health & Fitness category, maintaining a 4.2-star rating on the App Store. The absence of monetization signals a focus on user acquisition through specialized utility rather than revenue generation.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Peptide Tracker - Pepty
Where is it heading?
The health-utility market is shifting toward integrated, cloud-connected experiences. Peptide Tracker - Pepty remains in a stable maintenance posture, which serves its current users but leaves it vulnerable to competitors that offer more robust data backup and community-sharing features.
- The app maintains a steady maintenance-only release cadence, which keeps the current user base stable but prevents new growth.
- The absence of cloud-sync features creates a churn risk for users who upgrade devices, as they cannot migrate their history.
The SWOT
- Specialized reconstitution calculators provide utility that general-purpose trackers lack.
- Ad-free, subscription-free model removes friction for long-term health users.
- Automated vial expiration reminders could further differentiate the app.
- Community-shared protocol templates could build network effects.
Next best moves
Ship cloud-sync because data loss is a critical risk for health-tracking users → increase long-term retention
+ 1 more prioritized moveThe counter-intuitive read
Users report: The app's lack of monetization is its greatest competitive advantage…
Read the full takeSince the last report: The addition of cloud-sync limitations to the SWOT and PM action items marks a shift toward addressing long-term user retention risks. This change highlights a move from purely functional maintenance to addressing critical data persistence gaps.
Bottom line
Peptide Tracker - Pepty provides essential utility for a niche health segment, but the lack of cloud-sync limits its viability for long-term users. Prioritizing data persistence would unlock higher retention and solidify the app's position against general-purpose competitors.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated